[持续性姿势-感知性头晕]

[Persistent postural-perceptual dizziness].

作者信息

Esin R G, Khairullin I Kh, Mukhametova E R, Esin O R

机构信息

Kazan State Medical Academy, Kazan, Russia; Kazan Federal University, Kazan, Russia.

Kazan Federal University, Kazan, Russia.

出版信息

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(4):28-33. doi: 10.17116/jnevro20171174128-33.

DOI:10.17116/jnevro20171174128-33

PMID:28617375

Abstract

AIM

To study persistent postural perceptual dizziness (PPPD) in outpatients with benign paroxysmal positional vertigo (BPPV) and patients with presbiataxia (PAt).

MATERIAL AND METHODS

Eighty-four patients with PPPD, including 14 with Meniere's disease (MD), 19 with BPPV, 17 with a history of ischemic stroke (IS) in the vertebrobasilar system and 34 with Pat, were examined. For the diagnosis of anxiety, the original 15-point questionnaire with the Likert Scale structure was used. Patients received anvifen (aminophenylbutyric acid hydrochloride) in dose of 250 mg 3 times a day for 6 weeks. Results and сonclusion. The most common trigger of PPPD was sleep deprivation. The highest level of anxiety was identified in the PAt group (19,5±2,89). There was a good effect of the drug: it reduced anxiety in all patients studied. The quality of sleep was improved as well. The authors recommend anvifen as the drug of choice in patients with PPPD during vestibular rehabilitation and cognitive-behavioral therapy.

摘要

目的

研究门诊良性阵发性位置性眩晕（BPPV）患者和老年共济失调（PAt）患者的持续性姿势性感知性头晕（PPPD）。

材料与方法

对84例PPPD患者进行了检查，其中包括14例梅尼埃病（MD）患者、19例BPPV患者、17例有椎基底动脉系统缺血性卒中（IS）病史的患者以及34例PAt患者。对于焦虑症的诊断，使用了具有李克特量表结构的原始15分问卷。患者接受剂量为250毫克的安维芬（盐酸氨基苯丁酸），每日3次，共6周。结果与结论。PPPD最常见的诱发因素是睡眠剥夺。PAt组的焦虑水平最高（19.5±2.89）。该药物有良好效果：它降低了所有研究患者的焦虑。睡眠质量也得到了改善。作者推荐安维芬作为PPPD患者在前庭康复和认知行为治疗期间的首选药物。